UBR5 is a novel regulator of WNK1 stability

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• With no lysine (K) 1 (WNK1) protein kinase is crucial for cellular ion homeostasis.
• Dysregulation of WNK1 accumulation causes pseudohypoaldosteronism type II (PHAII), a form of familial hypertension.
• WNK1 is typically degraded by the ubiquitin-proteasome system via the Cullin3-RBX1 E3 ligase complex.

Purpose of the Study:

• To investigate the primary mechanisms of WNK1 protein turnover.
• To determine the kinetics of WNK1 protein degradation.
• To identify novel regulators of WNK1 protein stability.

Main Methods:

• Measurement of WNK1 protein decay rate after translation blockade in HeLa cells.
• Assessment of WNK1 degradation using proteasome and lysosome inhibitors.
• Analysis of WNK1 interaction with E3 ubiquitin ligase UBR5 and its effect on WNK1 stability.

Main Results:

• WNK1 protein degradation exhibits atypical kinetics.
• WNK1 is degraded by both the proteasome and the lysosome.
• Non-lysosomal cysteine proteases calpain and caspases also influence WNK1 degradation.
• The E3 ubiquitin ligase UBR5 interacts with WNK1, and its deficiency increases WNK1 protein levels.
• UBR5 deficiency leads to reduced lysosomal degradation of WNK1.

Conclusions:

• WNK1 protein turnover involves multiple degradative pathways, including lysosomal degradation.
• UBR5 is a novel regulator of WNK1 protein stability, promoting its lysosomal degradation.
• Understanding WNK1 degradation pathways is critical for addressing hypertension and related disorders.